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1. Introduction
There is a proliferation of products appearing 
on the market that claim major impact in 
increasing crop productivity. However, most 
of them have proved to be ineffective in both 
greenhouse and field conditions and no or 
inadequate data is available to assess their 
real effect. These products demand rigorous 
testing to verify whether they fulfill the claims 
of the manufacturer. The proliferation of the 
underperforming products can therefore be 
prevented, and value can be added to effective 
products. TSBF-CIAT has been mandated by 
Bill and Melinda Gate Foundation to scientifically 
evaluate and select effective commercial 
products for improving and sustaining crop 
yields in selected agro ecological zones in 
Kenya, Nigeria, Niger and Ethiopia.
2. Overall objective 
To assess the bacterial content of various 
commercial agricultural products in comparison 
to the information given by the private companies.
3. Materials and Methods
The bacterial strains contained in the commercial 
products were isolated on 2 media: NA (Nutrient 
Agar) which is a non selective media and allows 
the growth of most microorganisms and YEMA 
(Yeast Extract Mannitol Agar) which is a slightly 
selective media, and allows the growth of 
Rhizobium. Identification of the strains was done 
following DNA extraction from liquid cultures 
and PCR amplification of the 16S rDNA using 
universal primers (27f and 1492r). The PCR 
products (rDNA 16S amplified fragments) were 
submitted for sequencing at SegoliP Unit and 
the sequence data compared to gene libraries 
(Genbank) with BLAST (Basic Local Alignment 
Search Tool) (Altschul et al., 1990) program.
About 100 strains were isolated from 27 products 
that are classified into 3 categories as follows:
CATEGORY STRAINS MODE OF FUNCTION
I Rhizobial inoculants e.g. 
Bradyrhizobium sp., 
Mesorhizobium sp.,..
Biological Nitrogen 
Fixation
IIA Non-rhizobial bacteria 
e.g Azospirillum sp.
Free living nitrogen-fixing 
bacteria
IIB Other micro-organisms 
e.g. Bacillus sp.
Disease suppression, 
production of metabolites 
which promote general 
plant growth or aid in 
acquisition of less mobile 
nutrients (particularly P 
and Zn). 
4. Results
Product Category Producer Expected strains
No. of 
expected 
strains
No. of 
isolated 
strains
SEQUENCING
Confirmed as expected strains Other strains
Chick Pea 
Nodulator I
Becker Underwood 
 (USA) Mesorhizobium ciceri 1 1 Mesorhizobium ciceri, 98% -
Legumefix I Legume Technology (UK) Rhizobium spp. 1 1 Bradyrhizobium sp., 95% -
Peanutflo I SoyGro (South Africa) Bradyrhizobium sp. 1 5
Bradyrhizobium 
yuanmingense, 98%
Moraxella sp., 99%, 
Bacillus sp., 97%, 
*
Soyflo I SoyGro Ltd. (South Africa)
Bradyrhizobium japonicum 
 (strain WB74) 1 1 Bradyrhizobium japonicum, 95% -
Vault LVL I Becker Underwood (USA) Bradyrhizobium japonicum 1 3 Bradyrhizobium japonicum, 96%
Lysinibacillus sphaericus, 97%,
 Bacillus nealsonii, 98%
Bio N IIA Nutri-Tech Solutions (Australia) Azotobacter spp. 1 7 -
Bacillus megaterium, 98%, 
Bacillus licheniformis, 98%, 
Bacillus firmus, 99%, 
Brevibacillus brevis, 99%,
*
Bioplex IIA Nutri-Tech Solutions (Australia) Azotobacter spp. 1 5 -
Bacillus licheniformis, 98%, 
Stenotrophomonas sp., 80%,
 2 Bacillus spp., 98%,
*
Leguspirflo IIA SoyGro (South Africa) Azospirillum brasilense 1 4 Azospirillum brasilense, 94%
Bacillus sp., 97%,
 Paenibacillus polymyxa, 97%, 
Pantoea agglomerans, 97%
Mazospirflo 1 IIA SoyGro (South Africa) Azospirillum brasilense CD 1 3 Azospirillum brasilense, 98% *
Mazospirflo 2 IIA SoyGro (South Africa) Azospirillum brasilense CD 1 1 Azospirillum brasilense, 97% -
Rhizostim IIA SoyGro (South Africa) Azospirillum sp. 1 1 - Bacillus sp., 97%
Twin-N IIA Mapleton  (UK)
Azorhizobium sp.,  
Azoarcus sp.,  
Azospirillum sp.
3 2 Azorhizobium caulinodans, 98%, Azospirillum brasilense, 98% -
Integral IIB Becker Underwood  (USA)
Bacillus subtilis  
(strain MBI 600) 1 1 Bacillus subtilis, 97% -
Subtilex IIB Becker Underwood  (USA)
Bacillus subtilis  
(strain MBI 600) 1 1 Bacillus sp., 96%** -
Bac up IIB
Biological Control 
Products 
(South Africa)
Bacillus subtilis 1 2 Bacillus sp., 98%** Paenibacillus sp., 98%
Defender IIB Madumbi  (South Africa) Bacillus subtilis 1 2 Bacillus sp., 98%** Brevibacillus borstelensis, 97%
NIB PGPR  
peat inoculant IIB
Murdoch University 
(Australia) Pseudomonas sp. 1 1 Pseudomonas fluorescens, 95% -
MycoApply MAXX IIB
Mycorhizal 
Applications  
(USA)
Bacillus licheniformis,  
B.pumilis,  
B.amyloliquefaciens,
B.megaterium 
4 13 Bacillus megaterium, 97%, 5 Bacillus spp., 97%**
Paenibacillus lactis, 97%, Bacillus 
cereus, 97%, Brevibacillus 
borstelensis, 98%, Bacillus subtilis, 
98%, Paenibacillus polymyxa, 96%, 
Enterobacter pulveris, 97%,
 *
Myco Apply 
Soluble Maxx IIB
Mycorhizal 
Applications 
(USA)
Bacillus licheniformis, 
B.pumilis, B. azotoformans,
B. megaterium, 
B. coagulans,
B. thuringiensis,  
B. stearothermiphilis, 
Paenibacillus polymyxa,  
P. durum, P. Gordonae,  
Azotobacter polymyxa,  
A. chroococcum, 
Pseudomonas fluorescens, 
P. aureofaceans 
15 7 4 Bacillus spp., 98% **
Bacillus subtilis, 97%,
 Bacillus circulans, 100%, 
Enterobacter pulveris, 97%
B.Sub IIB Nutri-Tech Solutions  (Australia) Bacillus subtilis 1 4 Bacillus subtilis, 98%
Brevibacillus brevis, 96%, 
Bacillus cereus, 91%,
*
Accelerate IIB Nutri-Tech Solutions (Australia)
Bacillus polymyxa,  
Streptomyces spp. 2 5 Bacillus sp., 98%**
Bacillus subtilis, 98%, 
Bacillus firmus, 97%,
Bacillus vallismortis, 98%, 
Bacillus cereus, 98%
Myco tea IIB Nutri-Tech Solutions  (Australia)
Azotobacter chroococcum,
Bacillus polymyxa 2 5 -
Bacillus subtilis, 97%, 
Stenotrophomonas sp., 98%, 
Ochrobactrum intermedium, 99%,
 Cellulosimicrobium sp., 97%, 
Bacillus sp., 98%,
PHC Biopak IIB Plant Health Care  (USA)
B. licheniformis, B. subtilis,
B. megaterium, 
B. polymyxa,
B. thuringiensis,
Paenibacillus azotofixans
6 4
Bacillus subtilis, 98%, 
Bacillus megaterium, 97%,
 Bacillus 
licheniformis, 98%
Bacillus cereus, 96%
PHC Colonize AG IIB Plant Health Care (USA)
Paenibacillus azotofixans, 
Bacillus licheniformis,
B. megaterium, 
B. polymyxa,
B. subtilis, B. thuringiensis
6 3 Paenibacillus sp., 97%, Bacillus subtilis, 97% Bacillus cereus, 96%
PHC Complete 
plus IIB
Plant Health Care 
(USA)
Bacillus azotofixans,  
B. licheniformis, B. subtilis,
B. megaterium, 
B. polymyxa,
B. thuringiensis  
Streptomyces griseoviridis 
7 8 Bacillus thuringiensis, 96%,2 Bacillus spp., 97%**
Lysinibacillus fusiformis, 97%, 
Peanibacillus alvei, 97%,
 2 Lysinibacillus spp., 97%,
*
Fertosolflo - SoyGro  (South Africa) No information - 2
Bacillus sp., 96%, 
*
Nemablok - SoyGro  (South Africa) No information - 4
Bacillus sp., 97%,
 Burkholderia cepacia, 98%, 
*
*: remaining strains are under sequencing 
**: the species have not been determined
The results show that for half of the products 
(13 of 27), more strains than expected have 
been isolated. This could denote:
1. A remarkable level of contamination and 
this is regardless of the content of the 
products (about 50% of all the products in 
every category). 
2. The companies producing the products 
involved in this study do not give the entire 
information on the exact composition of 
the products and thus the strains are not 
obviously “contaminants”.
Generally, in the products supposed to contain 
a large number of bacterial species, less 
strains than expected have been isolated. 
This demonstrates the incapacity of too many 
bacteria to be present and active within a single 
product. For example, Myco Apply soluble maxx 
is supposed to contain 15 strains but only 7 
strains were isolated (less than 50%), same for 
PHC colonize which claims to contain 6 strains 
but only 3 strains were isolated.
Sequencing results show that only 33% of 
the products contain the expected strain(s) 
(most likely only one type of bacteria such 
as Bradyrhizobium or Bacillus) without any 
contamination and thus can be considered as 
“pure products”. On the other hand, products 
supposed to contain many types of bacteria 
are mainly highly contaminated (Bacillus, 
Enterobacter, Brevibacillus, Paenibacillus...) 
and only some of the expected strains are 
isolated. These “contaminated products” 
represent about 44% of the products. Eventually, 
about 15% of the products contain none of the 
expected strains but only contaminations. 
5. Conclusion
•	Presence of a variety of strains with different 
functions (N-fixation, disease suppression, 
nutrient uptake…) contained in the products.
•	Many private companies commercialize a 
mix of non-defined products and thus do 
not ensure the quality of their inoculums. 
This may explain their lack of impact on the 
plant growth under greenhouse conditions.
•	Companies do not provide sufficient 
information regarding the exact composition 
of the products.
•	Global high level of contamination: “Pure 
products”: represent 33% of the products 
only and 41% of the products contained all 
the expected strains (plus some others). 
52% of the products contain none or part 
of the expected strains and are highly 
contaminated.
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